Hexima Limited Price (HXL.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

167,039,629

(0)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.008-0.021
  • Market Cap 2.17M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Geoffrey Paul Kempler B.Sc.
  • IPO Date: November, 30, 2020
  • Country: AU
  • Currency: AUD
  • Headquaters: Preston, VIC
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation